Skip to main content
CLYMHealthcare

Climb Bio Inc (CLYM) Insider Trading

In the last 90 days, 1 Climb Bio Inc (CLYM) insider reported no open-market purchases and 1 sale totaling $1,366,820. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 15, 2026Stephen Basil ThomasDirectorSale100,000$13.67$1,366,820
Jun 29, 2026Aoife BrennanPresident and CEOSale30,902$13.17$406,979

Common questions

CLYM insider trading FAQ

Are CLYM insiders buying or selling?
Over the last 90 days, CLYM insiders were net sellers, reporting $0.00 of open-market purchases and $1,366,820 of sales.
When was the last CLYM insider purchase?
No open-market insider purchase of Climb Bio Inc stock was reported in the last 90 days.
Where does CLYM insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Climb Bio Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.